Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI)
- PMID: 6422174
- DOI: 10.1016/0024-3205(84)90014-6
Stimulation of presynaptic dopamine autoreceptors by 4-(2-di-n-propylaminoethyl) indole (DPAI)
Abstract
The dopaminergic activity of 4-(2-di-n-propylaminoethyl)indole (DPAI) was investigated. In animal models for postsynaptic dopaminergic activity DPAI showed only very weak or no effects. In rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal tract, very weak contralateral turning behavior was induced in 4/6 rats. DPAI did not induce stereotyped behavior but caused a pronounced reduction in locomotor activity. In male rats pretreated with reserpine, DPAI lowered serum prolactin levels. Levels of homovanillic acid (HVA) were monitored in the striatum of the chloral hydrate anesthetized rat by means of in vivo voltammetry. DPAI administration reduced the faradaic peak corresponding to HVA. In rats pretreated with the decarboxylase inhibitor, NSD-1015, DPAI blocked the accumulation of dopa in response to gamma-butyrolactone. The results of this study indicate that DPAI possesses a high degree of selectivity for presynaptic dopamine autoreceptors, and little or no effect on postsynaptic dopamine receptors.
Similar articles
-
7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.Life Sci. 1988;42(20):1941-54. doi: 10.1016/0024-3205(88)90493-6. Life Sci. 1988. PMID: 3130534
-
Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.J Clin Psychopharmacol. 1982 Dec;2(6):371-5. J Clin Psychopharmacol. 1982. PMID: 7174859
-
Preclinical studies on quinelorane, a potent and highly selective D2-dopaminergic agonist.J Pharmacol Exp Ther. 1989 Jul;250(1):227-35. J Pharmacol Exp Ther. 1989. PMID: 2526214
-
RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.J Pharmacol Exp Ther. 1983 Jan;224(1):161-70. J Pharmacol Exp Ther. 1983. PMID: 6401334
-
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].Encephale. 1979;5(2):121-49. Encephale. 1979. PMID: 38958 Review. French.
Cited by
-
Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.J Neural Transm. 1985;62(1-2):1-52. doi: 10.1007/BF01260414. J Neural Transm. 1985. PMID: 3894582 Review.
-
Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):494-501. doi: 10.1007/BF00169305. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 2830544
MeSH terms
Substances
LinkOut - more resources
Full Text Sources